Co-Authors
This is a "connection" page, showing publications co-authored by Licia Mota and Adriana Kakehasi.
Connection Strength
0.346
-
Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort. Clin Exp Rheumatol. 2021 Jul 07.
Score: 0.060
-
Effects of Participating in a Research Project During the COVID-19 Pandemic on Medical Students' Educational Routines and Mental Health: Protocol for a Web-Based Survey Study. JMIR Res Protoc. 2021 04 09; 10(4):e24617.
Score: 0.059
-
High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry. RMD Open. 2021 01; 7(1).
Score: 0.058
-
A Brazilian Cohort of Patients With Immuno-Mediated Chronic Inflammatory Diseases Infected by SARS-CoV-2 (ReumaCoV-Brasil Registry): Protocol for a Prospective, Observational Study. JMIR Res Protoc. 2020 Dec 15; 9(12):e24357.
Score: 0.057
-
Impact of Chronic Use of Antimalarials on SARS-CoV-2 Infection in Patients With Immune-Mediated Rheumatic Diseases: Protocol for a Multicentric Observational Cohort Study. JMIR Res Protoc. 2020 Oct 14; 9(10):e23532.
Score: 0.057
-
Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases. Adv Rheumatol. 2020 06 09; 60(1):32.
Score: 0.055